2018
From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea
Sinha C, Bakshi N, Ross D, Krishnamurti L. From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea. PLOS ONE 2018, 13: e0199375. PMID: 29949647, PMCID: PMC6021071, DOI: 10.1371/journal.pone.0199375.Peer-Reviewed Original ResearchConceptsSickle cell diseaseGroup 1 participantsGroup 2 participantsCell diseaseSide effectsAdult SCD patientsPatient-related factorsPotential side effectsAdult patientsSCD patientsHU usePatients' attitudesAge 31Age groupsAge 18PatientsYoung adultsEfficacySignificant differencesAdultsEffective alternativeDiseaseRiskParticipantsQualitative interviews
2009
National Healthcare Utilization Trends for Deep Vein Thrombosis in the United States.
Viswanathan P, Goswami U, Krishnamurti L. National Healthcare Utilization Trends for Deep Vein Thrombosis in the United States. Blood 2009, 114: 3183. DOI: 10.1182/blood.v114.22.3183.3183.Peer-Reviewed Original ResearchNationwide Inpatient SampleLow molecular weight heparinPostoperative pulmonary embolismDeep vein thrombosisHealth care utilizationMolecular weight heparinPrimary diagnosisSecondary diagnosisPulmonary embolismVein thrombosisAnnual incidenceCare utilizationWeight heparinDischarge diagnosisHospital utilizationAge 18ICD-9-CM diagnosisLarge-scale prospective studiesCommon primary diagnosisPatients age 18Primary discharge diagnosisPulmonary heart diseaseAcute care hospitalsVariety of diagnosesHealthcare utilization trends